Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study

Fig. 4

Odds ratio (OR) values for the association between individual metabolites (LPC, lysophosphatidylcholine; PC, phosphatidylcholine) and prostate cancer risk after restriction to case-controls with baseline normal glucose tolerance (NGT). Left: overall prostate cancer in subjects aged 40–60 years (387 matched case-control sets), 40–50 years (198 sets) and 60 years (189 sets). Centre: non-aggressive prostate cancer in subjects aged 40–60 years (311 sets), 40–50 years (173 sets) and 60 years (138 sets). Right: aggressive prostate cancer in subjects aged 40–60 years (76 sets n = 152), 40–50 years (25 sets) and 60 years (51 sets). Black filled circles: ORNGT > ORcrude. Black open circles: ORNGT < ORcrude. *pNGT < 0.05. **pNGT < 0.05 and pNGT < pcrude

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us